This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Bioniche Life Sciences Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Marc Riviere
Introduction
Marc Riviere is a notable inventor based in Saint Lambert, Canada. He has made significant contributions to the field of medicine, particularly in the treatment of liver disorders and viral infections. His innovative approach has the potential to impact many lives positively.
Latest Patents
Marc Riviere holds a patent for the use of imatinib to treat liver disorders and viral infections. This invention specifically relates to the application of imatinib for treating viral liver diseases, especially viral hepatitis. The patent outlines the use of imatinib for inhibiting the replication and transmission of hepatitis viruses. Furthermore, it extends to other viruses, including herpes virus, poxvirus, influenza virus, and several others.
Career Highlights
Marc Riviere is associated with Bioniche Life Sciences Inc., where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in his organization.
Collaborations
Some of his coworkers include Phillippe Riviere and Stéphanie Reader, who contribute to the collaborative efforts within the company.
Conclusion
Marc Riviere's work exemplifies the spirit of innovation in the medical field. His patent for the use of imatinib showcases his commitment to addressing significant health challenges. Through his contributions, he continues to pave the way for advancements in treatment options for viral infections and liver disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile